These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 9563885

  • 1. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 2. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [Abstract] [Full Text] [Related]

  • 3. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 5. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb 15; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometry: a new approach for the molecular profiling of breast cancer.
    Lostumbo A, Mehta D, Setty S, Nunez R.
    Exp Mol Pathol; 2006 Feb 15; 80(1):46-53. PubMed ID: 16271361
    [Abstract] [Full Text] [Related]

  • 7. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS, Bacus JW, Slamon DJ, Press MF.
    Arch Pathol Lab Med; 1990 Feb 15; 114(2):164-9. PubMed ID: 1967930
    [Abstract] [Full Text] [Related]

  • 8. Common patterns of genetic evolution in human solid tumors.
    Shackney SE, Shankey TV.
    Cytometry; 1997 Sep 01; 29(1):1-27. PubMed ID: 9298807
    [Abstract] [Full Text] [Related]

  • 9. EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR.
    Gschwantler-Kaulich D, Hudelist G, Koestler WJ, Czerwenka K, Mueller R, Helmy S, Ruecklinger E, Kubista E, Singer CF.
    Oncol Rep; 2005 Aug 01; 14(2):305-11. PubMed ID: 16012707
    [Abstract] [Full Text] [Related]

  • 10. Preferred genetic evolutionary sequences in human breast cancer: a case study.
    Shackney SE, Smith CA, Pollice AA, Janocko LE, Singh SG, Groft DW, Brown KA, Hartsock RJ.
    Cytometry; 1995 Sep 01; 21(1):6-13. PubMed ID: 8529472
    [Abstract] [Full Text] [Related]

  • 11. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan 01; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 12. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D, Thor AD.
    J Clin Oncol; 2005 Feb 20; 23(6):1152-60. PubMed ID: 15718311
    [Abstract] [Full Text] [Related]

  • 13. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO.
    Mod Pathol; 1994 Feb 20; 7(2):257-62. PubMed ID: 7911998
    [Abstract] [Full Text] [Related]

  • 14. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

  • 15. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R.
    Cancer; 2006 Aug 15; 107(4):696-704. PubMed ID: 16826579
    [Abstract] [Full Text] [Related]

  • 16. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C, Voigt JJ, Laplanche A, Culine S, Lortholary A, Bugat R, Theodore C, Priou F, Kaminsky MC, Lesimple T, Pivot X, Coudert B, Douillard JY, Merrouche Y, Fizazi K.
    Br J Cancer; 2007 Oct 08; 97(7):857-61. PubMed ID: 17876336
    [Abstract] [Full Text] [Related]

  • 17. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):309-17. PubMed ID: 15890569
    [Abstract] [Full Text] [Related]

  • 18. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES.
    Proteomics; 2005 May 01; 5(7):1797-805. PubMed ID: 15825149
    [Abstract] [Full Text] [Related]

  • 19. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications.
    Shackney SE, Pollice AA, Smith CA, Alston L, Singh SG, Janocko LE, Brown KA, Petruolo S, Groft DW, Yakulis R, Hartsock RJ.
    Cancer J Sci Am; 1996 May 01; 2(2):106-13. PubMed ID: 9166508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.